BURLINGTON, ON,
May 1, 2014 /CNW/ - EcoSynthetix Inc.
(TSX: ECO) ("EcoSynthetix" or the "Company"), a renewable chemicals
company that produces a family of commercially proven bio-based
products, today announced its financial results for the three
months ended March 31, 2014.
Financial references are in U.S. dollars unless otherwise
indicated.
First Quarter 2014 Highlights
- Net sales were $5.0 million for
the three months ended March 31, 2014
(Q1 2014) compared to $6.1 million in
the three months ended March 31, 2013
(Q1 2013)
- Introduced a new grade of EcoSphere®
biolatex® which has been shown to be an optimal
formulation for specific applications in the paperboard,
lightweight coated paper and fine graphic paper segment
- Won two new customers during the quarter
- Appointed Jeff MacDonald as its
Chief Operating Officer to lead business development, sales,
operations and product development activities subsequent to quarter
end
"Our new grades of EcoSphere biolatex continue to drive new
customer trials. Our versatile binders offer formulation
alternatives for the paper and paperboard market, while we pursue
larger market applications for our bio-polymers in building
material products," said John van
Leeuwen, Chief Executive Officer. "With our focused R&D
and sales efforts, we are confident that our expanding product
pipeline will accelerate our growth."
Financial Summary
Net Sales
Net sales were $5.0
million in Q1 2014 compared to $6.1
million in Q1 2013. The change in sales was principally due
to lower sales volume in EMEA, Asia
Pacific and Latin America,
which decreased $0.7 million,
$0.5 million and $0.2 million, respectively. The decrease in sales
in EMEA was primarily due to the closure of a customer's coated
paper production line in Q4 2013. Sales in Asia Pacific continue to be negatively
impacted by the over-supply of butadiene and related drop in
styrene-butadiene (SB) latex prices. These changes in sales were
partly offset by higher sales volume to existing commercial
accounts in North America of
$0.4 million. EcoSynthetix won two
new customers during the current quarter.
Gross Profit
Gross profit was $1.0
million in Q1 2014, or 19.7% of sales, compared to
$1.1 million, or 17.3% of sales, in
Q1 2013.
Gross profit adjusted for manufacturing
depreciation as a percentage of sales increased to 25.7% in Q1 2014
compared to 22.3% in Q1 2013. The change was primarily due to lower
raw material costs.
Selling, General and Administrative
(Excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Selling, general and administrative (SG&A)
costs were $2.6 million for Q1 2014
compared to $3.0 million in Q1 2013.
The decrease was principally due to lower salaries and benefits and
the favourable impact of the weakening Canadian dollar relative to
the U.S. dollar in Q1 2014.
Research and Development
(Excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Research and development (R&D) expenses were
$1.5 million in Q1 2014 compared to
$1.3 million in Q1 2013. R&D is a
key focus of EcoSynthetix to enhance its bio-engineered product
portfolio and expand into new applications and markets. The
increase was primarily due to increased trial activity in order to
bring new products to market compared to Q1 of last year.
Adjusted EBITDA1
Adjusted EBITDA for the quarter was ($2.8) million, compared to ($2.9) million in Q1 2013. The decrease in
adjusted EBITDA loss is due to lower operating expenses partly
offset by lower gross profit.
Net Loss
Net loss in Q1 2014 was $3.3 million, or $0.06 per common share, compared to $3.5 million, or $0.06 per share, for Q1 2013. The change in net
loss is principally due to a decrease in loss from operations.
Liquidity
Working capital was $84.3
million at March 31, 2014
compared to working capital of $87.3
million at December 31,
2013. The decrease in working capital was principally
due to cash utilized in operating activities.
Notice of Conference Call
EcoSynthetix will host a conference call on
Friday, May 2, 2014, at 8:30 AM ET to discuss its financial
results. John van Leeuwen,
CEO, and Robert Haire, CFO, will
co-chair the call. All interested parties can join the call by
dialling (647) 427-7450 or (888) 231-8191. Please dial in 15
minutes prior to the call to secure a line. A live audio webcast of
the conference call will also be available on the Investor
Relations Events page at www.ecosynthetix.com. The presentation
will be accompanied by slides, which will be available via the
webcast link and the Company's website. Please connect at least 15
minutes prior to the conference call to ensure adequate time for
any software download that may be required to join the webcast.
1Non-IFRS Financial
Measures
This press release makes reference to certain
non-IFRS measures. These non-IFRS measures are not recognized
measures under IFRS, do not have a standardized meaning prescribed
by IFRS and are therefore unlikely to be comparable to similar
measures presented by other companies. Rather, these measures are
provided as additional information to complement those IFRS
measures by providing a further understanding of results of
operations of EcoSynthetix from management's perspective.
Accordingly, they should not be considered in isolation nor as a
substitute for analysis of the financial information of
EcoSynthetix reported under IFRS. The Company uses non-IFRS
measures such as Adjusted EBITDA to provide investors with a
supplemental measure of operating performance and thus highlight
trends in its core business that may not otherwise be apparent when
relying solely on IFRS financial measures. Management also believes
that securities analysts, investors and other interested parties
frequently use non-IFRS measures in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, prepare
annual operating budgets and assess the Company's ability to meet
its capital expenditure and working capital requirements.
Adjusted EBITDA is not a measure recognized
under IFRS and does not have a standardized meaning prescribed by
IFRS. The Company presents Adjusted EBITDA because the Company
believes it facilitates investors' use of operating performance
comparisons from period to period and company to company by backing
out potential differences caused by variations in capital
structures (affecting relative interest expense), the book
amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein is not a recognized measure under IFRS and should not be
considered as an alternative to operating income or net income as a
measure of operating results or an alternative to cash flows as a
measure of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before interest, income taxes, depreciation,
amortization and other non-cash expenses deducted in determining
consolidated net income (loss) before interest, income taxes,
depreciation, amortization, other non-cash expenses and charges
which include the movement in the unrealized gains and losses on
the Company's redeemable preferred shares and warrants classified
as financial liabilities prior to the initial public offering and
share based compensation expense.
The following table reconciles net loss to
Adjusted EBITDA for Q1 2014 and Q1 2013:
|
|
|
|
|
|
Three months ended |
|
|
March 31, 2014 |
March 31, 2013 |
Net loss |
(3,322,254) |
(3,533,486) |
Depreciation and amortization |
429,919 |
381,907 |
Share-based compensation |
135,000 |
331,103 |
Interest Income |
(83,101) |
(85,372) |
Adjusted EBITDA (1) |
(2,840,436) |
(2,905,848) |
About EcoSynthetix Inc.
(www.ecosynthetix.com)
EcoSynthetix Inc. is a renewable chemicals company specializing in
bio-based products that can be used as inputs in industrial
manufacturing for a wide range of consumer products. The Company's
products offer a reduced carbon footprint and are marketed
primarily on the basis of lower cost, stable pricing and equal or
superior performance. EcoSynthetix's lead product,
EcoSphere® biolatex® binders, is used
commercially by a number of the global top 20 manufacturers in the
coated paper and paperboard industry.
Forward Looking Statements
Certain statements in this Press Release constitute "forward
looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. These statements reflect our
current views regarding future events and operating performance and
are based on information currently available to us, and speak only
as of the date of this Press Release. These forward looking
statements involve a number of risks, uncertainties and assumptions
and should not be read as guarantees of future performance or
results, and will not necessarily be accurate indications of
whether or not such performance or results will be achieved. Those
assumptions and risks include, but are not limited to, the fact
that our results of operations and business outlook are subject to
significant risk, volatility and uncertainty. Many factors could
cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such forward
looking statements, including the factors identified in the "Risk
Factors" section of the Company's Annual Information Form dated
March 31, 2014. Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward looking statements prove incorrect, actual
results may vary materially from those described in this Press
Release as intended, planned, anticipated, believed, estimated or
expected. Unless required by applicable securities law, we do not
intend and do not assume any obligation to update these forward
looking statements.
EcoSynthetix Inc. |
|
|
|
Interim Consolidated Balance
Sheets |
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
(expressed in US dollars) |
|
|
|
|
|
|
|
|
March
31,
2014 |
|
December 31,
2013 |
|
|
|
|
Assets |
|
|
|
|
|
|
|
Current assets |
|
|
|
Cash |
77,212,911 |
|
80,506,957 |
Accounts receivable |
3,534,237 |
|
3,691,791 |
Inventory |
6,327,289 |
|
6,470,410 |
Government grants receivable |
344,022 |
|
261,648 |
Prepaid expenses |
271,247 |
|
276,856 |
|
87,689,706 |
|
91,207,662 |
|
|
|
|
Non-current assets |
|
|
|
Intangible assets |
119,831 |
|
124,009 |
Property, plant and
equipment |
12,651,943 |
|
12,775,188 |
|
|
|
|
Total assets |
100,461,480 |
|
104,106,859 |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
Accounts payable and accrued
liabilities |
3,373,150 |
|
3,947,385 |
|
|
|
|
Total liabilities |
3,373,150 |
|
3,947,385 |
|
|
|
|
Shareholders' Equity |
|
|
|
|
|
|
|
Common shares |
492,732,150 |
|
492,600,022 |
|
|
|
|
Contributed surplus |
7,780,831 |
|
7,661,849 |
|
|
|
|
Accumulated deficit |
(403,424,651) |
|
(400,102,397) |
|
|
|
|
Total shareholders'
equity |
97,088,330 |
|
100,159,474 |
|
|
|
|
Total liabilities and
shareholders' equity |
100,461,480 |
|
104,106,859 |
EcoSynthetix Inc. |
|
|
|
Interim Consolidated
Statements of Operations and Comprehensive Loss
|
(Unaudited) |
|
|
|
For the three months
ended March 31, 2014 and March 31, 2013
|
|
|
|
|
(expressed in US dollars) |
|
|
|
|
|
|
|
|
|
|
2014 |
|
2013 |
|
|
|
|
Net sales |
4,994,064 |
|
6,120,478 |
|
|
|
|
Cost of sales |
4,011,075 |
|
5,064,352 |
|
|
|
|
Gross profit on sales |
982,989 |
|
1,056,126 |
|
|
|
|
Expenses |
|
|
|
Selling, general and
administrative |
2,844,083 |
|
3,405,462 |
Research and development |
1,544,261 |
|
1,269,522 |
|
|
|
|
|
4,388,344 |
|
4,674,984 |
|
|
|
|
Loss from operations |
(3,405,355) |
|
(3,618,858) |
|
|
|
|
Interest income |
83,101 |
|
85,372 |
|
|
|
|
Net loss and comprehensive
loss |
(3,322,254) |
|
(3,533,486) |
|
|
|
|
Basic and diluted loss per common
share |
(0.06) |
|
(0.06) |
|
|
|
|
Weighted average number of common
shares outstanding |
56,731,241 |
|
55,689,778 |
EcoSynthetix
Inc. |
|
|
|
Interim Consolidated
Statements of Cash Flows |
|
|
|
(Unaudited) |
|
|
|
For the three months
ended March 31, 2014 and March 31, 2013 |
|
|
|
|
|
(expressed in US
dollars) |
|
|
|
|
|
|
2014 |
|
2013 |
Cash provided by (used
in) |
|
|
|
|
|
|
|
Operating
activities |
|
|
|
Net loss |
(3,322,254) |
|
(3,533,486) |
Items not affecting
cash |
|
|
|
|
Depreciation and
amortization |
429,919 |
|
381,907 |
|
Share-based compensation |
135,000 |
|
331,103 |
Changes in non-cash
working capital |
|
|
|
|
Accounts receivable |
157,554 |
|
(379,649) |
|
Inventory |
70,821 |
|
(1,000,062) |
|
Government grants receivable |
(82,374) |
|
3,619 |
|
Prepaid expenses |
5,609 |
|
(67,192) |
|
Accounts payable and accrued
liabilities |
(574,233) |
|
1,548,543 |
|
Deferred government assistance |
- |
|
(103,030) |
|
|
|
|
|
(3,179,958) |
|
(2,818,247) |
|
|
|
|
Investing
activities |
|
|
|
Cash used for purchase of
intangible assets and property, plant and equipment
|
(230,198) |
|
(467,190) |
|
|
|
|
Financing
activities |
|
|
|
Exercise of common share
options |
27,930 |
|
234,879 |
Exercise of warrants |
160,058 |
|
- |
Repurchase of common
shares |
(71,878) |
|
- |
|
|
|
|
|
116,110 |
|
234,879 |
|
|
|
|
Change in cash during
the period |
(3,294,046) |
|
(3,050,558) |
|
|
|
|
Cash - Beginning of
period |
80,506,957 |
|
93,260,296 |
|
|
|
|
Cash - End of
period |
77,212,911 |
|
90,209,738 |
SOURCE EcoSynthetix Inc.